Complete Genomics SEC Filing Points to Interest from Another Potential Bidder | GenomeWeb

NEW YORK (GenomeWeb News) – A filing by Complete Genomics with the US Securities and Exchange Commission Wednesday suggests that another firm may be interested in entering the bidding to acquire the firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.